Cargando…
Cancer phenotype as the outcome of an evolutionary game between normal and malignant cells
BACKGROUND: There is variability in the cancer phenotype across individuals: two patients with the same tumour may experience different disease life histories, resulting from genetic variation within the tumour and from the interaction between tumour and host. Until now, phenotypic variability has p...
Autores principales: | Dingli, D, Chalub, F A C C, Santos, F C, Van Segbroeck, S, Pacheco, J M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768082/ https://www.ncbi.nlm.nih.gov/pubmed/19724279 http://dx.doi.org/10.1038/sj.bjc.6605288 |
Ejemplares similares
-
Reply: Evolutionary game theory: lessons and limitations, a cancer perspective
por: Dingli, D, et al.
Publicado: (2009) -
The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesothelioma
por: Pinato, D J, et al.
Publicado: (2013) -
Investigating prostate cancer tumour–stroma interactions: clinical and biological insights from an evolutionary game
por: Basanta, D, et al.
Publicado: (2012) -
Nucleostemin mRNA is expressed in both normal and malignant renal tissues
por: Fan, Y, et al.
Publicado: (2006) -
Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells
por: Kraan, J, et al.
Publicado: (2014)